Rein Therapeutics Inc.
RNTX | NASDAQ
$0.79
$0 (-0.57%)
Sep 22, 2026, 10:51 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -20.76M | -21.55M | -21.93M | -23.77M | -24.35M | -17.49M | -11.88M | -6.09M | -25.52K | -18.47K | -11.27K | -3.98K | -1.99K |
Interest Income | n/a | n/a | n/a | 700 | 700 | 700 | 700 | 600 | 600 | 600 | 600 | n/a | n/a |
Pretax Income | -50.47M | -50.92M | -50.58M | -60.43M | -60.7M | -53.88M | -48.39M | -5.87M | -25.22K | -18.07K | -10.95K | -3.61K | -1.79K |
Net Income | -49.76M | -50.21M | -49.87M | -58.89M | -59.15M | -52.34M | -46.84M | -5.87M | -25.22K | -18.07K | -10.95K | -3.61K | -1.79K |
Selling & General & Admin | 10.36M | 10.5M | 10.9M | 11.42M | 9.96M | 7.38M | 4.83M | 2.36M | 16.33K | 12.92K | 9.18K | 3.85K | 1.89K |
Research & Development | 10.39M | 11.05M | 11.03M | 12.35M | 14.39M | 10.1M | 7.05M | 3.73M | 9.2K | 5.64K | 2.18K | 209 | 187 |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12 | -6 | -94 | -94 | -82 | -88 |
Operating Expenses | 20.76M | 21.55M | 21.93M | 23.77M | 24.35M | 17.49M | 11.88M | 6.09M | 25.52K | 18.47K | 11.27K | 3.98K | 1.99K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.76M | 21.55M | 21.93M | 23.77M | 24.35M | 17.49M | 11.88M | 6.09M | 25.52K | 18.47K | 11.27K | 3.98K | 1.99K |
Income Tax Expense | -712K | -712K | -712K | -1.54M | -1.54M | -1.54M | -1.54M | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 67.08M | 30.35M | 25.44M | 26.36M | 24.19M | 22.94M | 21.69M | 21.66M | 19.91M | 8.3M | 4.77M | 4.54M | 4.54M |
Shares Outstanding (Diluted) | 67.08M | 30.35M | 25.44M | 26.36M | 24.19M | 22.94M | 21.69M | 21.66M | 19.91M | 8.3M | 4.77M | 4.54M | 4.54M |
EPS (Basic) | -1.72 | -1.90 | -1.95 | -2.62 | -2.68 | -2.85 | -3.47 | -3.12 | -3.25 | -3.19 | -2.33 | -0.79 | -0.39 |
EPS (Diluted) | -1.72 | -1.90 | -1.95 | -2.62 | -2.68 | -2.85 | -3.47 | -3.12 | -3.25 | -3.19 | -2.33 | -0.79 | -0.39 |
EBITDA | -21.04M | -21.49M | -21.77M | -60.43M | -60.69M | -53.88M | -48.39M | -5.87M | -25.21K | -18.34K | -11.28K | -4.03K | -2.07K |
EBIT | -21.66M | -22.11M | -21.77M | -60.43M | -60.7M | -53.88M | -48.39M | -5.87M | -25.33K | -18.47K | -11.36K | -4.06K | -2.08K |
Depreciation & Amortization | 623K | 624K | 1K | 1K | 1K | 4 | 63 | 115 | 127 | 135 | 76 | 24 | 12 |
Add to Watchlist
Select watchlists to add or remove RNTX